Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 600
Selected: 0
NCT IDTitle
NCT02269267The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)
NCT01908777A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma
NCT00592865Risk Factors for Adult-Onset Brain Tumors
NCT00694551PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment
NCT00434109Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization
NCT01435122A Study of Axitinib in Advanced Carcinoid Tumors
NCT01859026A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation
NCT03176576Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population
NCT07033598Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia
NCT05921552Senior Adult Hepatobiliary Prehab Study
NCT06553885Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
NCT06001268Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)
NCT01927120In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis
NCT00365872External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma
NCT03543969Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
NCT04588545Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease
NCT07030400Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma
NCT00597038A Phase I/II Study of Dasatinib and Dacarbazine
NCT02945787Spanish-Language Smoking Cessation Trial
NCT04760847Intermittent Fasting for Pancreatitis
NCT00823511The Human Papillomavirus (HPV) Transmission Pilot Study
NCT01253148Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma
NCT04464668Colorectal Cancer Awareness, Research and Education and Screening - Rural Expansion, Access and Capacity for Health
NCT07047885Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)
NCT00601796Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer
NCT01324180Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)
NCT04714983DNX-2440 for Resectable Colorectal Liver Metastasis
NCT00215995Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas
NCT05664178Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology
NCT03112590Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer
NCT00762255A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma
NCT00005800Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer
NCT05704933Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases
NCT00598507Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma
NCT01455311Evaluation of Image-guided Brushing of Pancreatic Cyst Wall in Diagnosis of Cystic Pancreatic Tumors
NCT03232411Biobank for African American Prostate Cancer Research in Florida
NCT05076760MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
NCT01347034Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS)
NCT02779855Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
NCT00360828Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas
NCT00005792Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
NCT01111526Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD)
NCT04163718TGR-1202 (Umbralisib) in Treatment Naïve Patients With Chronic Lymphocytic Leukemia (CLL)
NCT05065866Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy
NCT00226577Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.
NCT00005641Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
NCT03370276Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
NCT06855212Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC
NCT06497569Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer
NCT01048723Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal Sarcomas